CONCORD MANUFACTURING CRIT-LINE III BLOODCHAMBER II; ACCESSORIES, BLOOD CIRCUIT, HEMODIALYSIS
|
Back to Search Results |
|
Catalog Number 191058 |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 06/05/2017 |
Event Type
malfunction
|
Manufacturer Narrative
|
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
|
|
Event Description
|
A user facility's administrative assistance reported that a patient experienced blood loss while undergoing hemodialysis (hd) treatment on a (b)(4) hd machine.The following details were provided.The crit-line iii blood-chamber ii device disconnected from the optiflux (b)(4) dialyzer with 15 to 20 minutes left in the hd treatment.The blood within the arterial line of the extracorporeal circuit was returned and the hd therapy was discontinued.The patient's estimated blood loss (ebl) was noted as being approximately 520 milliliters (ml).The patient's condition was fine.No patient adverse effects were experienced and no medical intervention was required as a result of this event.No malfunction of the (b)(4) hd machine was observed or identified, prior to, during, or following the hd treatment.There was no allegation that a bloodline malfunction occurred.The machine, dialyzer, bloodlines, and blood chamber were not available to be returned to the manufacturer for evaluation.
|
|
Manufacturer Narrative
|
The sample is not available for evaluation as it was discarded at the facility.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint sample.Distribution records were reviewed to identify potential lots of this product shipped to the customer.The review included a check of non-conformance's, rework, labeling, process controls, and any other occurrence in production potentially related to the reported complaint.The lot passed all release criteria.
|
|
Event Description
|
A user facility's administrative assistance reported that a patient experienced blood loss while undergoing hemodialysis (hd) treatment on a 2008k2 hd machine.The following details were provided.The crit-line iii bloodchamber ii device disconnected from the optiflux f200nr dialyzer with 15 to 20 minutes left in the hd treatment.The blood within the arterial line of the extracorporeal circuit was returned and the hd therapy was discontinued.The patient's estimated blood loss (ebl) was noted as being approximately 520 milliliters (ml).The patient's condition was fine.No patient adverse effects were experienced and no medical intervention was required as a result of this event.No malfunction of the 2008k2 hd machine was observed or identified, prior to, during, or following the hd treatment.There was no allegation that a bloodline malfunction occurred.The machine, dialyzer, bloodlines, and blood chamber were not available to be returned to the manufacturer for evaluation.
|
|
Manufacturer Narrative
|
The device was not returned to the manufacturer for physical evaluation and the failure mode cannot be confirmed.As the serial number of the alleged blood chamber product was not provided, an investigation of the device manufacturing records could not be conducted by the manufacturer.Please be advised all device history records (dhr) are reviewed and released according to the dhr review checklist and release procedure.A device is not released if it does not meet requirements or is nonconforming.
|
|
Event Description
|
A user facility's administrative assistance reported that a patient experienced blood loss while undergoing hemodialysis (hd) treatment on a 2008k2 hd machine.The following details were provided.The crit-line iii bloodchamber ii device disconnected from the optiflux f200nr dialyzer with 15 to 20 minutes left in the hd treatment.The blood within the arterial line of the extracorporeal circuit was returned and the hd therapy was discontinued.The patient's estimated blood loss (ebl) was noted as being approximately 520 milliliters (ml).The patient's condition was fine.No patient adverse effects were experienced and no medical intervention was required as a result of this event.No malfunction of the 2008k2 hd machine was observed or identified, prior to, during, or following the hd treatment.There was no allegation that a bloodline malfunction occurred.The machine, dialyzer, bloodlines, and blood chamber were not available to be returned to the manufacturer for evaluation.
|
|
Search Alerts/Recalls
|
|
|